Lead-Free Halide Perovskite Cs3 Bi2 x Sb2-2 x I9 (x ≈ 0.3) Possessing the Photocatalytic Activity for Hydrogen Evolution Comparable to that of (CH3 NH3 )PbI3

© 2020 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 32(2020), 39 vom: 01. Okt., Seite e2001344
1. Verfasser: Chen, Guoqiang (VerfasserIn)
Weitere Verfasser: Wang, Peng, Wu, Yaqiang, Zhang, Qianqian, Wu, Qian, Wang, Zeyan, Zheng, Zhaoke, Liu, Yuanyuan, Dai, Ying, Huang, Baibiao
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Cs3Bi2xSb2-2xI9 hydrogen-evolution solid solution lead-free perovskites photocatalysis
Beschreibung
Zusammenfassung:© 2020 Wiley-VCH GmbH.
Lead-free perovskites Cs3 Bi2 x Sb2-2 x I9 (x = 0.1, 0.3, 0.5, 0.7, 0.9) are prepared by a co-precipitation method and their photocatalytic performance for hydrogen production is studied in aqueous HI solution. Compared with the lead-based perovskite (CH3 NH3 )PbI3 , Cs3 Bi2 x Sb2-2 x I9 has a better catalytic performance under air mass 1.5 G (AM 1.5 G) simulated sunlight (100 mW cm-2 ), powders of Cs3 Bi0.6 Sb1.4 I9 (100 mg) loaded with Pt nanoparticles show < H2 evolution rate of 92.6 µmol h-1 , which greatly exceeds that of (CH3 NH3 )PbI3 powders loaded with Pt nanoparticles (100 mg catalyst, 4 µmol h-1 ). The Cs3 Bi2 x Sb2-2 x I9 has a high stability, with no apparent decrease in catalytic activity after five consecutive H2 evolution experiments. The doping of Sb in Cs3 Bi2 x Sb2-2 x I9 effectively reduces the contribution of Bi3+ on the conduction band, attenuating the effect of Bi vacancy on band structure. Compared with pure Cs3 Bi2 I9 and Cs3 Sb2 I9 , Cs3 Bi2 x Sb2-2 x I9 has fewer midgap states and better optical absorption, which greatly enhances its performance for the hydrogen evolution reaction
Beschreibung:Date Revised 07.12.2020
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202001344